Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease
Author:
Affiliation:
1. Division of Gastroenterology; Department of Medicine; Icahn School of Medicine at Mount Sinai; New York NY USA
2. Gastroenterology unit; Cochin University Hospital; Université Paris Descartes; Sorbonne Paris Cité; Paris France
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14550/fullpdf
Reference53 articles.
1. Vedolizumab as induction and maintenance therapy for Crohn's disease;Sandborn;N Engl J Med,2013
2. Vedolizumab as induction and maintenance therapy for ulcerative colitis;Feagan;N Engl J Med,2013
3. Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed;Sands;Gastroenterology,2014
4. Efficacy of vedolizumab as induction therapy in refractory IBD patients: a multicenter cohort;Shelton;Inflamm Bowel Dis,2015
5. Vedolizumab induction therapy for inflammatory bowel disease in clinical practice-a nationwide consecutive German cohort study;Baumgart;Aliment Pharmacol Ther,2016
Cited by 110 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and Safety of Ontamalimab in Treating Inflammatory Bowel Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials;Current Pharmacology Reports;2024-09-05
2. Lymphocyte subsets for predicting inflammatory bowel disease progression and treatment response: a systematic review;Frontiers in Immunology;2024-08-20
3. Oral Microbiota Associated with Clinical Efficacy of Ustekinumab in Crohn’s disease;2024-08-09
4. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08
5. Biologics in Focus: A Comprehensive Review of Current Biological and Small Molecules Therapies for Crohn’s Disease in the United Arab Emirates (UAE);Gastrointestinal Disorders;2024-07-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3